Edward Havranek
Concepts (459)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 50 | 2018 | 1952 | 2.460 |
Why?
| Hypertension | 20 | 2022 | 1059 | 2.440 |
Why?
| Antihypertensive Agents | 9 | 2021 | 429 | 2.000 |
Why?
| Medication Adherence | 10 | 2022 | 537 | 1.790 |
Why?
| Text Messaging | 5 | 2020 | 154 | 1.740 |
Why?
| Healthcare Disparities | 8 | 2023 | 480 | 1.590 |
Why?
| Socioeconomic Factors | 11 | 2021 | 1081 | 1.280 |
Why?
| Heart Diseases | 3 | 2019 | 330 | 1.200 |
Why?
| Social Values | 2 | 2021 | 36 | 1.180 |
Why?
| Racism | 3 | 2021 | 102 | 1.140 |
Why?
| Health Status | 12 | 2018 | 721 | 1.090 |
Why?
| Myocardial Infarction | 17 | 2015 | 929 | 1.010 |
Why?
| Blood Pressure | 9 | 2016 | 1537 | 0.990 |
Why?
| Weight Loss | 5 | 2018 | 642 | 0.970 |
Why?
| Social Determinants of Health | 2 | 2018 | 135 | 0.970 |
Why?
| Cardiovascular Diseases | 11 | 2019 | 1729 | 0.950 |
Why?
| Hospitalization | 24 | 2020 | 1754 | 0.940 |
Why?
| Out-of-Hospital Cardiac Arrest | 3 | 2019 | 78 | 0.910 |
Why?
| Prediabetic State | 2 | 2016 | 220 | 0.870 |
Why?
| Patient Satisfaction | 6 | 2019 | 583 | 0.850 |
Why?
| Health Services Accessibility | 2 | 2019 | 765 | 0.840 |
Why?
| Aged | 79 | 2021 | 19122 | 0.830 |
Why?
| Hypertrophy, Left Ventricular | 3 | 2008 | 103 | 0.800 |
Why?
| Attitude to Health | 2 | 2021 | 406 | 0.800 |
Why?
| Resuscitation Orders | 2 | 2020 | 45 | 0.800 |
Why?
| Sexual Health | 2 | 2020 | 46 | 0.790 |
Why?
| Humans | 141 | 2023 | 114937 | 0.790 |
Why?
| Middle Aged | 60 | 2022 | 26806 | 0.770 |
Why?
| Physician-Patient Relations | 5 | 2013 | 463 | 0.760 |
Why?
| Sexually Transmitted Diseases | 2 | 2020 | 155 | 0.740 |
Why?
| Health Status Disparities | 3 | 2021 | 201 | 0.740 |
Why?
| Male | 99 | 2022 | 55663 | 0.730 |
Why?
| Female | 102 | 2022 | 59581 | 0.730 |
Why?
| Depression | 8 | 2018 | 1134 | 0.710 |
Why?
| Residence Characteristics | 3 | 2021 | 275 | 0.680 |
Why?
| Primary Health Care | 4 | 2019 | 1515 | 0.660 |
Why?
| Cardiac Output, Low | 5 | 2006 | 64 | 0.660 |
Why?
| Atherosclerosis | 2 | 2019 | 342 | 0.630 |
Why?
| Diabetes Mellitus | 9 | 2018 | 904 | 0.630 |
Why?
| United States | 44 | 2023 | 12211 | 0.620 |
Why?
| Colorado | 22 | 2021 | 4091 | 0.610 |
Why?
| Choice Behavior | 1 | 2019 | 155 | 0.600 |
Why?
| Minority Groups | 3 | 2023 | 228 | 0.580 |
Why?
| Heart Arrest | 2 | 2020 | 289 | 0.550 |
Why?
| Communication | 4 | 2023 | 749 | 0.540 |
Why?
| American Heart Association | 3 | 2018 | 264 | 0.510 |
Why?
| Safety-net Providers | 2 | 2018 | 95 | 0.510 |
Why?
| Emergency Service, Hospital | 5 | 2021 | 1813 | 0.510 |
Why?
| Health Services Research | 2 | 2015 | 371 | 0.470 |
Why?
| Delivery of Health Care | 7 | 2023 | 834 | 0.460 |
Why?
| Risk Factors | 26 | 2019 | 8637 | 0.450 |
Why?
| Emergency Medical Services | 4 | 2023 | 587 | 0.450 |
Why?
| Aged, 80 and over | 29 | 2021 | 6364 | 0.440 |
Why?
| Blood Pressure Determination | 1 | 2014 | 122 | 0.430 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 679 | 0.420 |
Why?
| Adult | 30 | 2023 | 30608 | 0.410 |
Why?
| Guideline Adherence | 6 | 2021 | 490 | 0.400 |
Why?
| Decision Making | 2 | 2016 | 781 | 0.400 |
Why?
| Medically Uninsured | 1 | 2013 | 122 | 0.400 |
Why?
| Surveys and Questionnaires | 10 | 2018 | 4635 | 0.390 |
Why?
| Patient-Centered Care | 2 | 2016 | 473 | 0.390 |
Why?
| Decision Support Techniques | 1 | 2015 | 352 | 0.380 |
Why?
| Kidney Diseases | 3 | 2011 | 350 | 0.380 |
Why?
| Blood Pressure Monitoring, Ambulatory | 2 | 2011 | 61 | 0.380 |
Why?
| Cohort Studies | 26 | 2020 | 4903 | 0.380 |
Why?
| Follow-Up Studies | 17 | 2022 | 4427 | 0.370 |
Why?
| Physicians, Primary Care | 2 | 2018 | 222 | 0.370 |
Why?
| Ventricular Dysfunction, Left | 6 | 2008 | 360 | 0.370 |
Why?
| Survival Analysis | 7 | 2010 | 1220 | 0.370 |
Why?
| Carotid Artery Diseases | 1 | 2011 | 57 | 0.370 |
Why?
| Electrocardiography | 4 | 2009 | 562 | 0.370 |
Why?
| Insurance, Health | 1 | 2013 | 244 | 0.370 |
Why?
| Risk Assessment | 10 | 2019 | 2975 | 0.360 |
Why?
| Practice Patterns, Physicians' | 3 | 2018 | 1177 | 0.360 |
Why?
| Coronary Artery Disease | 3 | 2013 | 607 | 0.360 |
Why?
| Survival Rate | 13 | 2020 | 1644 | 0.320 |
Why?
| Quality of Life | 12 | 2019 | 2359 | 0.320 |
Why?
| Quality of Health Care | 7 | 2007 | 573 | 0.320 |
Why?
| Exercise | 2 | 2018 | 1643 | 0.320 |
Why?
| Cardiopulmonary Resuscitation | 3 | 2020 | 220 | 0.310 |
Why?
| Attitude to Death | 1 | 2008 | 60 | 0.310 |
Why?
| Heart Rate | 2 | 2011 | 705 | 0.300 |
Why?
| Proportional Hazards Models | 11 | 2015 | 1080 | 0.300 |
Why?
| Renin-Angiotensin System | 1 | 2008 | 71 | 0.300 |
Why?
| Patient Education as Topic | 4 | 2018 | 678 | 0.290 |
Why?
| Atrial Fibrillation | 2 | 2009 | 325 | 0.290 |
Why?
| Medicare | 14 | 2017 | 666 | 0.290 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 8 | 2008 | 180 | 0.290 |
Why?
| Retrospective Studies | 30 | 2020 | 12544 | 0.280 |
Why?
| Stroke | 3 | 2021 | 1019 | 0.280 |
Why?
| Sex Factors | 10 | 2020 | 1721 | 0.270 |
Why?
| Kidney | 3 | 2011 | 1184 | 0.270 |
Why?
| Diabetic Angiopathies | 4 | 2009 | 244 | 0.270 |
Why?
| Models, Statistical | 2 | 2013 | 604 | 0.270 |
Why?
| Cross-Sectional Studies | 14 | 2017 | 4407 | 0.260 |
Why?
| Prevalence | 7 | 2018 | 2252 | 0.260 |
Why?
| Value of Life | 1 | 2005 | 19 | 0.250 |
Why?
| Young Adult | 9 | 2021 | 10478 | 0.240 |
Why?
| Insurance, Health, Reimbursement | 2 | 2017 | 88 | 0.240 |
Why?
| Multivariate Analysis | 10 | 2017 | 1440 | 0.240 |
Why?
| Palliative Care | 4 | 2016 | 640 | 0.240 |
Why?
| Prognosis | 9 | 2018 | 3344 | 0.240 |
Why?
| Ambulances | 2 | 2023 | 50 | 0.240 |
Why?
| Monitoring, Ambulatory | 1 | 2005 | 81 | 0.230 |
Why?
| Patient Compliance | 4 | 2018 | 526 | 0.230 |
Why?
| Peer Review, Research | 1 | 2004 | 34 | 0.230 |
Why?
| Epidemiologic Studies | 1 | 2004 | 57 | 0.230 |
Why?
| Attitude of Health Personnel | 2 | 2012 | 978 | 0.220 |
Why?
| Single-Blind Method | 2 | 2021 | 258 | 0.220 |
Why?
| Treatment Outcome | 15 | 2023 | 9105 | 0.220 |
Why?
| Nisoldipine | 1 | 2003 | 6 | 0.220 |
Why?
| Enalapril | 1 | 2003 | 16 | 0.220 |
Why?
| Smoking Cessation | 1 | 2007 | 374 | 0.220 |
Why?
| Pneumonia | 2 | 2019 | 568 | 0.220 |
Why?
| Hypoglycemic Agents | 5 | 2012 | 1008 | 0.220 |
Why?
| Shock, Traumatic | 1 | 2023 | 16 | 0.220 |
Why?
| Social Class | 2 | 2019 | 204 | 0.210 |
Why?
| Sepsis | 2 | 2019 | 508 | 0.210 |
Why?
| Prospective Studies | 12 | 2019 | 6218 | 0.210 |
Why?
| Sexual Behavior | 3 | 2020 | 440 | 0.210 |
Why?
| Critical Illness | 2 | 2023 | 643 | 0.210 |
Why?
| Delivery of Health Care, Integrated | 1 | 2005 | 229 | 0.200 |
Why?
| Mexican Americans | 2 | 2015 | 102 | 0.200 |
Why?
| Communication Barriers | 1 | 2023 | 89 | 0.200 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2017 | 2096 | 0.200 |
Why?
| Perception | 1 | 2004 | 311 | 0.200 |
Why?
| Intention to Treat Analysis | 1 | 2021 | 68 | 0.200 |
Why?
| Telemedicine | 2 | 2011 | 665 | 0.190 |
Why?
| Glomerular Filtration Rate | 5 | 2011 | 604 | 0.190 |
Why?
| Electronic Health Records | 2 | 2018 | 802 | 0.190 |
Why?
| Acculturation | 2 | 2012 | 50 | 0.190 |
Why?
| Stroke Volume | 7 | 2008 | 510 | 0.190 |
Why?
| Cardiologists | 2 | 2018 | 40 | 0.180 |
Why?
| Adolescent | 10 | 2020 | 17829 | 0.180 |
Why?
| Drug Prescriptions | 6 | 2009 | 239 | 0.180 |
Why?
| Brain Ischemia | 2 | 2021 | 299 | 0.180 |
Why?
| Incidence | 6 | 2021 | 2316 | 0.180 |
Why?
| Writing | 1 | 2021 | 85 | 0.180 |
Why?
| Professional-Patient Relations | 1 | 2021 | 140 | 0.180 |
Why?
| Age Factors | 11 | 2018 | 2891 | 0.180 |
Why?
| Chronic Disease | 6 | 2018 | 1593 | 0.170 |
Why?
| Chi-Square Distribution | 5 | 2015 | 495 | 0.170 |
Why?
| Time Factors | 10 | 2015 | 6125 | 0.160 |
Why?
| Cardiology | 3 | 2007 | 259 | 0.160 |
Why?
| Quality Assurance, Health Care | 6 | 2007 | 313 | 0.160 |
Why?
| Health Care Surveys | 4 | 2019 | 539 | 0.160 |
Why?
| Fluid Therapy | 1 | 2020 | 122 | 0.160 |
Why?
| Shock | 1 | 2020 | 75 | 0.160 |
Why?
| Qualitative Research | 3 | 2019 | 936 | 0.160 |
Why?
| Income | 1 | 2019 | 167 | 0.160 |
Why?
| Public Opinion | 1 | 2019 | 59 | 0.160 |
Why?
| Patient Selection | 5 | 2009 | 642 | 0.160 |
Why?
| Patient Care Team | 2 | 2018 | 516 | 0.160 |
Why?
| Formative Feedback | 1 | 2018 | 23 | 0.150 |
Why?
| Severity of Illness Index | 3 | 2019 | 2542 | 0.150 |
Why?
| Emergency Treatment | 1 | 2019 | 113 | 0.150 |
Why?
| Medical Audit | 1 | 2018 | 75 | 0.150 |
Why?
| Patient Readmission | 5 | 2012 | 608 | 0.150 |
Why?
| Withholding Treatment | 2 | 2016 | 68 | 0.150 |
Why?
| Contraception | 1 | 2019 | 117 | 0.150 |
Why?
| Health Literacy | 2 | 2018 | 164 | 0.150 |
Why?
| Censuses | 1 | 2017 | 18 | 0.150 |
Why?
| Multilevel Analysis | 1 | 2017 | 26 | 0.150 |
Why?
| California | 1 | 2019 | 363 | 0.150 |
Why?
| Patient Navigation | 1 | 2019 | 64 | 0.150 |
Why?
| Angina Pectoris | 2 | 2008 | 63 | 0.150 |
Why?
| Odds Ratio | 6 | 2018 | 954 | 0.150 |
Why?
| Hyperglycemia | 3 | 2010 | 292 | 0.140 |
Why?
| Peer Group | 1 | 2019 | 203 | 0.140 |
Why?
| Interviews as Topic | 3 | 2015 | 582 | 0.140 |
Why?
| Goals | 1 | 2018 | 151 | 0.140 |
Why?
| International Cooperation | 1 | 2018 | 172 | 0.140 |
Why?
| Comorbidity | 9 | 2012 | 1458 | 0.140 |
Why?
| ST Elevation Myocardial Infarction | 1 | 2017 | 50 | 0.140 |
Why?
| Statistics as Topic | 3 | 2008 | 294 | 0.140 |
Why?
| Logistic Models | 9 | 2017 | 1844 | 0.140 |
Why?
| Program Development | 1 | 2018 | 345 | 0.140 |
Why?
| Leadership | 2 | 2018 | 295 | 0.130 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 1183 | 0.130 |
Why?
| Self-Management | 1 | 2018 | 126 | 0.130 |
Why?
| Hospital Mortality | 5 | 2019 | 776 | 0.130 |
Why?
| Urban Population | 1 | 2018 | 402 | 0.130 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 65 | 0.130 |
Why?
| Weight Reduction Programs | 1 | 2017 | 94 | 0.130 |
Why?
| Registries | 6 | 2020 | 1760 | 0.130 |
Why?
| Organizational Case Studies | 1 | 2015 | 69 | 0.130 |
Why?
| Diuretics | 3 | 2006 | 66 | 0.130 |
Why?
| Predictive Value of Tests | 4 | 2010 | 1801 | 0.130 |
Why?
| Cell Phone | 1 | 2016 | 77 | 0.130 |
Why?
| Renal Dialysis | 1 | 2019 | 369 | 0.120 |
Why?
| Xanthines | 2 | 2007 | 15 | 0.120 |
Why?
| Clinical Decision-Making | 1 | 2017 | 269 | 0.120 |
Why?
| Diffusion of Innovation | 1 | 2015 | 94 | 0.120 |
Why?
| Education, Medical | 1 | 2018 | 222 | 0.120 |
Why?
| Exercise Test | 1 | 2017 | 545 | 0.120 |
Why?
| Thiazolidinediones | 3 | 2005 | 142 | 0.120 |
Why?
| Hypercholesterolemia | 1 | 2015 | 90 | 0.120 |
Why?
| Community Health Services | 2 | 2008 | 212 | 0.120 |
Why?
| Organizational Innovation | 1 | 2015 | 133 | 0.120 |
Why?
| Organizational Culture | 1 | 2015 | 119 | 0.120 |
Why?
| Lipoproteins | 1 | 2015 | 160 | 0.120 |
Why?
| Cultural Competency | 2 | 2013 | 72 | 0.120 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 122 | 0.120 |
Why?
| Acute Coronary Syndrome | 1 | 2017 | 254 | 0.120 |
Why?
| Blood Vessels | 1 | 2016 | 180 | 0.120 |
Why?
| ROC Curve | 2 | 2020 | 448 | 0.120 |
Why?
| Adiponectin | 1 | 2015 | 213 | 0.120 |
Why?
| Practice Guidelines as Topic | 4 | 2017 | 1400 | 0.120 |
Why?
| Ventricular Function, Left | 4 | 2009 | 468 | 0.120 |
Why?
| Pilot Projects | 3 | 2015 | 1372 | 0.110 |
Why?
| Cholesterol | 1 | 2015 | 368 | 0.110 |
Why?
| Aspirin | 3 | 2005 | 324 | 0.110 |
Why?
| Kidney Failure, Chronic | 1 | 2019 | 488 | 0.110 |
Why?
| Creatinine | 5 | 2006 | 424 | 0.110 |
Why?
| Triglycerides | 1 | 2015 | 470 | 0.110 |
Why?
| Disease Management | 3 | 2008 | 563 | 0.110 |
Why?
| Inpatients | 5 | 2009 | 380 | 0.100 |
Why?
| Metformin | 3 | 2005 | 278 | 0.100 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2005 | 1215 | 0.100 |
Why?
| Diabetes Complications | 3 | 2009 | 211 | 0.100 |
Why?
| Kaplan-Meier Estimate | 2 | 2015 | 817 | 0.100 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 372 | 0.100 |
Why?
| Hyperlipidemias | 1 | 2012 | 122 | 0.100 |
Why?
| Trust | 1 | 2012 | 105 | 0.100 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1700 | 0.100 |
Why?
| Adiposity | 1 | 2015 | 457 | 0.090 |
Why?
| Pregnancy | 2 | 2020 | 5527 | 0.090 |
Why?
| Biomedical Research | 2 | 2007 | 585 | 0.090 |
Why?
| Vascular Stiffness | 1 | 2015 | 408 | 0.090 |
Why?
| Hospitals, Military | 1 | 2011 | 33 | 0.090 |
Why?
| Medical Laboratory Science | 1 | 2010 | 7 | 0.090 |
Why?
| Health Promotion | 1 | 2017 | 686 | 0.090 |
Why?
| Diet | 2 | 2015 | 1077 | 0.090 |
Why?
| Adrenergic beta-Antagonists | 3 | 2008 | 288 | 0.090 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 128 | 0.090 |
Why?
| Affect | 1 | 2012 | 246 | 0.090 |
Why?
| Body Mass Index | 2 | 2016 | 1961 | 0.090 |
Why?
| Telephone | 1 | 2011 | 152 | 0.090 |
Why?
| Double-Blind Method | 4 | 2015 | 1663 | 0.090 |
Why?
| Health Status Indicators | 3 | 2008 | 154 | 0.080 |
Why?
| Nutrition Surveys | 2 | 2008 | 224 | 0.080 |
Why?
| Obesity | 2 | 2015 | 2514 | 0.080 |
Why?
| Infant, Newborn | 1 | 2019 | 5035 | 0.080 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2009 | 146 | 0.080 |
Why?
| Longitudinal Studies | 3 | 2011 | 2382 | 0.080 |
Why?
| Pharmacists | 1 | 2011 | 236 | 0.080 |
Why?
| Captopril | 1 | 2008 | 11 | 0.080 |
Why?
| Valsartan | 1 | 2008 | 22 | 0.080 |
Why?
| Tetrazoles | 1 | 2008 | 32 | 0.080 |
Why?
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 29 | 0.080 |
Why?
| Spironolactone | 2 | 2005 | 28 | 0.080 |
Why?
| Spirituality | 1 | 2009 | 69 | 0.080 |
Why?
| Spouse Abuse | 1 | 2008 | 36 | 0.080 |
Why?
| Health Surveys | 1 | 2010 | 443 | 0.080 |
Why?
| Valine | 1 | 2008 | 72 | 0.070 |
Why?
| Linear Models | 4 | 2015 | 770 | 0.070 |
Why?
| Carbazoles | 1 | 2008 | 78 | 0.070 |
Why?
| Adenosine A1 Receptor Antagonists | 1 | 2007 | 2 | 0.070 |
Why?
| Patients | 1 | 2009 | 162 | 0.070 |
Why?
| Insulin Resistance | 1 | 2015 | 1072 | 0.070 |
Why?
| Propanolamines | 1 | 2008 | 90 | 0.070 |
Why?
| Medical Records Systems, Computerized | 1 | 2008 | 90 | 0.070 |
Why?
| Medically Underserved Area | 1 | 2008 | 81 | 0.070 |
Why?
| United States Department of Veterans Affairs | 1 | 2011 | 557 | 0.070 |
Why?
| Social Workers | 2 | 2018 | 32 | 0.070 |
Why?
| Vascular Diseases | 1 | 2009 | 230 | 0.070 |
Why?
| Self Care | 1 | 2009 | 350 | 0.070 |
Why?
| Defibrillators, Implantable | 1 | 2010 | 286 | 0.070 |
Why?
| Biomarkers | 6 | 2015 | 3418 | 0.070 |
Why?
| Blood Urea Nitrogen | 1 | 2006 | 51 | 0.070 |
Why?
| Internal Medicine | 1 | 2008 | 211 | 0.070 |
Why?
| Coronary Artery Bypass | 2 | 2006 | 198 | 0.070 |
Why?
| Patient Admission | 4 | 2009 | 175 | 0.060 |
Why?
| National Health Programs | 1 | 2005 | 20 | 0.060 |
Why?
| Diet, Sodium-Restricted | 1 | 2006 | 32 | 0.060 |
Why?
| Dyspnea | 2 | 2018 | 218 | 0.060 |
Why?
| Body Temperature | 1 | 2006 | 208 | 0.060 |
Why?
| Fatigue | 2 | 2018 | 296 | 0.060 |
Why?
| Cost of Illness | 2 | 2004 | 254 | 0.060 |
Why?
| Patient Discharge | 4 | 2006 | 769 | 0.060 |
Why?
| Self Report | 2 | 2022 | 696 | 0.060 |
Why?
| Asthma | 1 | 2018 | 2042 | 0.060 |
Why?
| Edema | 1 | 2006 | 119 | 0.060 |
Why?
| Patient Reported Outcome Measures | 2 | 2018 | 250 | 0.060 |
Why?
| Nurses | 2 | 2018 | 144 | 0.060 |
Why?
| Health Education | 1 | 2008 | 322 | 0.060 |
Why?
| Natriuretic Peptide, Brain | 1 | 2005 | 96 | 0.060 |
Why?
| Hospital Costs | 1 | 2005 | 103 | 0.060 |
Why?
| Interinstitutional Relations | 1 | 2005 | 55 | 0.060 |
Why?
| Drug Costs | 1 | 2005 | 91 | 0.060 |
Why?
| Terminally Ill | 1 | 2005 | 33 | 0.060 |
Why?
| Specialization | 1 | 2005 | 115 | 0.060 |
Why?
| Cardiac Pacing, Artificial | 1 | 2005 | 79 | 0.060 |
Why?
| Nurse Practitioners | 1 | 2006 | 102 | 0.060 |
Why?
| Depressive Disorder | 1 | 2007 | 332 | 0.060 |
Why?
| Counseling | 1 | 2007 | 342 | 0.060 |
Why?
| Coronary Care Units | 1 | 2004 | 13 | 0.060 |
Why?
| United Kingdom | 1 | 2005 | 227 | 0.060 |
Why?
| Anemia | 1 | 2005 | 144 | 0.060 |
Why?
| Multicenter Studies as Topic | 1 | 2005 | 250 | 0.060 |
Why?
| Alcohol Drinking | 2 | 2009 | 655 | 0.060 |
Why?
| Nurse Administrators | 1 | 2004 | 32 | 0.060 |
Why?
| Educational Status | 1 | 2006 | 409 | 0.060 |
Why?
| Medicine | 1 | 2005 | 102 | 0.060 |
Why?
| Cultural Characteristics | 1 | 2004 | 59 | 0.060 |
Why?
| Internet | 1 | 2008 | 599 | 0.060 |
Why?
| North America | 1 | 2004 | 257 | 0.060 |
Why?
| Ibuprofen | 1 | 2003 | 74 | 0.050 |
Why?
| Vulnerable Populations | 1 | 2004 | 133 | 0.050 |
Why?
| Albuminuria | 1 | 2004 | 164 | 0.050 |
Why?
| Needs Assessment | 1 | 2005 | 315 | 0.050 |
Why?
| Thiazoles | 1 | 2003 | 110 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2003 | 115 | 0.050 |
Why?
| Weight Gain | 1 | 2006 | 451 | 0.050 |
Why?
| South Africa | 1 | 2023 | 161 | 0.050 |
Why?
| Continuity of Patient Care | 1 | 2005 | 254 | 0.050 |
Why?
| Health Behavior | 2 | 2011 | 704 | 0.050 |
Why?
| Bayes Theorem | 1 | 2004 | 331 | 0.050 |
Why?
| Risk Reduction Behavior | 1 | 2004 | 200 | 0.050 |
Why?
| Cooperative Behavior | 1 | 2005 | 383 | 0.050 |
Why?
| Diuresis | 1 | 2002 | 8 | 0.050 |
Why?
| Purinergic P1 Receptor Antagonists | 1 | 2002 | 7 | 0.050 |
Why?
| Ambulatory Care | 2 | 2006 | 479 | 0.050 |
Why?
| Hypertension, Malignant | 1 | 2002 | 2 | 0.050 |
Why?
| Furosemide | 1 | 2002 | 32 | 0.050 |
Why?
| Cardiac Tamponade | 1 | 2002 | 14 | 0.050 |
Why?
| Pain Measurement | 1 | 2004 | 446 | 0.050 |
Why?
| Total Quality Management | 1 | 2002 | 62 | 0.050 |
Why?
| Hospice Care | 1 | 2005 | 185 | 0.050 |
Why?
| Lupus Nephritis | 1 | 2002 | 52 | 0.050 |
Why?
| Health Care Costs | 1 | 2004 | 380 | 0.050 |
Why?
| Algorithms | 1 | 2008 | 1474 | 0.050 |
Why?
| Mortality | 2 | 2018 | 288 | 0.050 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 299 | 0.050 |
Why?
| Health Maintenance Organizations | 2 | 2012 | 93 | 0.050 |
Why?
| Blood Glucose | 2 | 2009 | 1821 | 0.040 |
Why?
| Veterans | 1 | 2011 | 1240 | 0.040 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2003 | 400 | 0.040 |
Why?
| Emergencies | 1 | 2021 | 146 | 0.040 |
Why?
| Contraindications | 3 | 2005 | 85 | 0.040 |
Why?
| Family Practice | 1 | 2004 | 427 | 0.040 |
Why?
| Confidence Intervals | 2 | 2012 | 309 | 0.040 |
Why?
| Length of Stay | 2 | 2017 | 949 | 0.040 |
Why?
| Coronary Disease | 1 | 2002 | 347 | 0.040 |
Why?
| Risk Adjustment | 1 | 2020 | 75 | 0.040 |
Why?
| Area Under Curve | 1 | 2020 | 275 | 0.040 |
Why?
| Sexuality | 1 | 2019 | 19 | 0.040 |
Why?
| Electric Countershock | 1 | 2019 | 104 | 0.040 |
Why?
| Research | 2 | 2018 | 395 | 0.040 |
Why?
| Geographic Mapping | 1 | 2018 | 21 | 0.040 |
Why?
| Hospitals | 1 | 2003 | 581 | 0.040 |
Why?
| Program Evaluation | 2 | 2018 | 824 | 0.040 |
Why?
| Alcoholism | 1 | 2004 | 715 | 0.040 |
Why?
| Zimbabwe | 1 | 2018 | 42 | 0.040 |
Why?
| Patient Health Questionnaire | 1 | 2018 | 20 | 0.040 |
Why?
| Palliative Medicine | 1 | 2018 | 14 | 0.040 |
Why?
| Anxiety | 2 | 2018 | 846 | 0.040 |
Why?
| Cholesterol, LDL | 2 | 2012 | 307 | 0.040 |
Why?
| Combined Modality Therapy | 2 | 2011 | 1126 | 0.040 |
Why?
| Capacity Building | 1 | 2018 | 51 | 0.040 |
Why?
| Time-to-Treatment | 1 | 2018 | 147 | 0.040 |
Why?
| Resuscitation | 1 | 2020 | 247 | 0.040 |
Why?
| Analysis of Variance | 1 | 2020 | 1227 | 0.030 |
Why?
| Secondary Prevention | 1 | 2018 | 221 | 0.030 |
Why?
| Sex Distribution | 1 | 2017 | 336 | 0.030 |
Why?
| Emotional Adjustment | 1 | 2016 | 17 | 0.030 |
Why?
| Peer Review | 2 | 2007 | 43 | 0.030 |
Why?
| Primary Prevention | 1 | 2018 | 171 | 0.030 |
Why?
| Sex Offenses | 1 | 2019 | 148 | 0.030 |
Why?
| Respiration, Artificial | 1 | 2020 | 526 | 0.030 |
Why?
| Feasibility Studies | 1 | 2019 | 737 | 0.030 |
Why?
| Diet Surveys | 1 | 2015 | 78 | 0.030 |
Why?
| Population Surveillance | 1 | 2018 | 392 | 0.030 |
Why?
| Motivation | 1 | 2020 | 495 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 87 | 0.030 |
Why?
| Emergency Medicine | 1 | 2018 | 220 | 0.030 |
Why?
| Insurance Coverage | 1 | 2017 | 202 | 0.030 |
Why?
| Neoplasms | 1 | 2009 | 2106 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2016 | 208 | 0.030 |
Why?
| Canada | 2 | 2006 | 322 | 0.030 |
Why?
| Medical Records | 2 | 2006 | 154 | 0.030 |
Why?
| Healthy Volunteers | 1 | 2015 | 197 | 0.030 |
Why?
| Language | 1 | 2017 | 258 | 0.030 |
Why?
| Consensus | 2 | 2007 | 534 | 0.030 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2002 | 928 | 0.030 |
Why?
| Mineralocorticoid Receptor Antagonists | 2 | 2005 | 38 | 0.030 |
Why?
| Administration, Oral | 2 | 2007 | 731 | 0.030 |
Why?
| Regression Analysis | 2 | 2009 | 947 | 0.030 |
Why?
| Pain Management | 1 | 2016 | 289 | 0.030 |
Why?
| Aging | 1 | 2003 | 1621 | 0.030 |
Why?
| Stereotyped Behavior | 1 | 2012 | 19 | 0.030 |
Why?
| Up-Regulation | 1 | 2015 | 812 | 0.030 |
Why?
| Quality Indicators, Health Care | 2 | 2006 | 287 | 0.030 |
Why?
| Pain | 1 | 2018 | 710 | 0.030 |
Why?
| Disease Progression | 2 | 2011 | 2392 | 0.030 |
Why?
| Cardiac Resynchronization Therapy | 1 | 2012 | 42 | 0.020 |
Why?
| Culture | 1 | 2012 | 122 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 2 | 2007 | 1856 | 0.020 |
Why?
| Speech Recognition Software | 1 | 2010 | 11 | 0.020 |
Why?
| Cause of Death | 1 | 2012 | 363 | 0.020 |
Why?
| User-Computer Interface | 1 | 2010 | 144 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2018 | 1477 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 60 | 0.020 |
Why?
| Medication Therapy Management | 1 | 2010 | 67 | 0.020 |
Why?
| Hospitals, University | 1 | 2008 | 171 | 0.020 |
Why?
| Natriuresis | 1 | 2007 | 8 | 0.020 |
Why?
| Patient Participation | 1 | 2010 | 360 | 0.020 |
Why?
| Kidney Function Tests | 1 | 2007 | 140 | 0.020 |
Why?
| Ontario | 1 | 2006 | 74 | 0.020 |
Why?
| Risk | 1 | 2009 | 815 | 0.020 |
Why?
| Sleep Wake Disorders | 1 | 2009 | 232 | 0.020 |
Why?
| Pravastatin | 1 | 2006 | 28 | 0.020 |
Why?
| Lovastatin | 1 | 2006 | 26 | 0.020 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2006 | 47 | 0.020 |
Why?
| Heptanoic Acids | 1 | 2006 | 60 | 0.020 |
Why?
| Databases as Topic | 1 | 2005 | 63 | 0.020 |
Why?
| Hematocrit | 1 | 2005 | 85 | 0.020 |
Why?
| Family | 1 | 2009 | 590 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2007 | 718 | 0.020 |
Why?
| Cognition Disorders | 1 | 2009 | 476 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2005 | 102 | 0.020 |
Why?
| Hospitals, Urban | 1 | 2005 | 127 | 0.020 |
Why?
| Midwestern United States | 1 | 2004 | 38 | 0.020 |
Why?
| Northwestern United States | 1 | 2004 | 53 | 0.020 |
Why?
| Pyrroles | 1 | 2006 | 183 | 0.020 |
Why?
| Cognition | 1 | 2012 | 983 | 0.020 |
Why?
| Potassium | 1 | 2005 | 128 | 0.020 |
Why?
| Age Distribution | 1 | 2005 | 340 | 0.010 |
Why?
| Hospitals, Municipal | 1 | 2004 | 1 | 0.010 |
Why?
| Myocardial Revascularization | 1 | 2004 | 67 | 0.010 |
Why?
| Disease-Free Survival | 1 | 2006 | 623 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1391 | 0.010 |
Why?
| Indoles | 1 | 2006 | 306 | 0.010 |
Why?
| Anti-Arrhythmia Agents | 1 | 2004 | 106 | 0.010 |
Why?
| Drug Utilization | 1 | 2004 | 167 | 0.010 |
Why?
| Drug Utilization Review | 1 | 2003 | 57 | 0.010 |
Why?
| Arrhythmias, Cardiac | 1 | 2005 | 279 | 0.010 |
Why?
| Fee-for-Service Plans | 1 | 2003 | 83 | 0.010 |
Why?
| Overweight | 1 | 2006 | 472 | 0.010 |
Why?
| Cardiotonic Agents | 1 | 2003 | 119 | 0.010 |
Why?
| Pyridines | 1 | 2006 | 425 | 0.010 |
Why?
| Drug Interactions | 1 | 2003 | 347 | 0.010 |
Why?
| Electrolytes | 1 | 2002 | 55 | 0.010 |
Why?
| Urinalysis | 1 | 2002 | 63 | 0.010 |
Why?
| Sodium | 1 | 2002 | 182 | 0.010 |
Why?
| Drug Combinations | 1 | 2002 | 286 | 0.010 |
Why?
| Diabetic Nephropathies | 1 | 2004 | 234 | 0.010 |
Why?
| Cardiac Catheterization | 1 | 2004 | 535 | 0.010 |
Why?
| Morbidity | 1 | 2002 | 277 | 0.010 |
Why?
| Referral and Consultation | 1 | 2005 | 634 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 2003 | 954 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2002 | 441 | 0.010 |
Why?
| Mental Disorders | 1 | 2008 | 891 | 0.010 |
Why?
| Heart Ventricles | 1 | 2005 | 711 | 0.010 |
Why?
| Substance-Related Disorders | 1 | 2008 | 946 | 0.010 |
Why?
| Recovery of Function | 1 | 2003 | 572 | 0.010 |
Why?
| Case-Control Studies | 1 | 2005 | 3008 | 0.010 |
Why?
| Hemodynamics | 1 | 2002 | 1014 | 0.010 |
Why?
| Internship and Residency | 1 | 2004 | 944 | 0.010 |
Why?
|
|
Havranek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|